19 Aug 2015 07:00
For immediate release | 19 August 2015 |
Â
Â
Â
Â
Â
Â
Â
Â
Â
Futura Medical plc
("Futura" or the "Company")
Â
Notice of Interim Results
Â
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2015 on Wednesday 9 September 2015.
Â
A briefing for analysts will be held at 9.30am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.
Â
There will be a live webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 9.30am on the day of results:
http://vm.buchanan.uk.com/2015/futuramedical090915/registration.htmÂ
A recording of the webcast will also be made available at www.futuramedical.com and www.buchanan.uk.com, following the results meeting.
Â
For more information, or to register attendance, please contact Buchanan on 020 7466 5000.
Â
For further information please contact:
Â
Futura Medical plc | |
James Barder, Chief Executive | Tel: +44 (0) 1483 685 670 |
Email to: james.barder@futuramedical.com | www.futuramedical.com |
 N+1 Singer (Nominated Adviser and Broker) | |
Aubrey Powell / Tom Smale - Corporate Finance  | Tel:+44 (0) 20 7496 3000 |
For media enquiries please contact: | |
Buchanan | |
Mark Court / Sophie Cowles / Stephanie Watson | Tel: +44 (0) 20 7466 5000 |
Â
Notes to Editors
Â
Futura Medical plc
Â
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Â
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
Â
www.futuramedical.com
Â
Â